Differential response to a combination of full-dose osimertinib and crizotinib in a patient with EGFR-mutant non-small cell lung cancer and emergent MET amplification

Viola W Zhu,1 Alexa B Schrock,2 Siraj M Ali,2 Sai-Hong Ignatius Ou1 1Chao Family Comprehensive Cancer Center, Division of Hematology/Oncology, Department of Medicine, University of California, Irvine School of Medicine, Orange, CA, USA; 2Clinical Development, Foundation Medicine, Inc., Cambridge, MA...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhu VW, Schrock AB, Ali SM, Ou SI
Format: article
Language:EN
Published: Dove Medical Press 2019
Subjects:
MET
Online Access:https://doaj.org/article/92497f75a8b94fb7b5a39d98c3997684
Tags: Add Tag
No Tags, Be the first to tag this record!